Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Learn which Dividend Aristocrats ETF charges the lowest fees and how that can impact long-term performance. We compare expense ratios and help you choose smarter.
27,457 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Public fallout can shake more than your reputation—it can reshape your finances and family security. This article use...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
Meme coins surged with viral fame, but a political push to bar elected officials from launching them could reshape th...
When classic films return to theaters, it’s more than a trip down memory lane. It’s a teachable moment for your walle...
Wednesday brought a wave of fresh analyst calls spanning tech, industrials, and defense as traders weigh earnings and...
Flat home prices “mirror” a familiar 1990s pattern, signaling subtle shifts for buyers and investors. This article un...
The U.S. economy grew in the final months of last year, expanding at a 1.4% annual rate in Oct-Dec, but the pace slow...
When a well-known fund exits a position, it invites scrutiny. This fund dumped million in Graphic Packaging as shares...
Online buzz can influence money choices. This guide explains how analysis claims thousands bots may distort engagemen...
Zillow promotes three executives in a leadership reshuffle, elevating the chief product officer role and expanding th...
A rally in Cava lifted the restaurant group, but Sweetgreen’s disappointing sales offer pulled markets back, undersco...